Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the consensus of $59.35 billion.

The increase was primarily driven by significant growth in Evernorth Health Services, reflecting large client wins and strong specialty volume growth.

Adjusted income from operations for the third quarter of 2024 increased by 5%, reflecting strong contributions from Evernorth Health Services, particularly within Specialty and Care Services, partially offset by lower net investment income.

Also Read: Pharmacy Retailer CVS Health Backs Away From ...